提高口服抗癌药物依从性的行动呼吁。 - Suppr

Call to Action for Improving Oral Anticancer Agent Adherence.

作者信息

Levit Laura A, Arora Shaily, Kluetz Paul G, Magnuson Allison, Rahman Atiqur, Harvey R Donald

机构信息

American Society of Clinical Oncology, Alexandria, VA.

AstraZeneca, Gaithersburg, MD.

出版信息

J Clin Oncol. 2022 Apr 1;40(10):1036-1040. doi: 10.1200/JCO.21.02529. Epub 2022 Jan 6.

DOI:10.1200/JCO.21.02529

PMID:34990218

Abstract

摘要

相似文献

Call to Action for Improving Oral Anticancer Agent Adherence.

J Clin Oncol. 2022 Apr 1;40(10):1036-1040. doi: 10.1200/JCO.21.02529. Epub 2022 Jan 6.

Adherence to oral anticancer chemotherapies and estimation of the economic burden associated with unused medicines.

Int J Clin Pharm. 2020 Oct;42(5):1311-1318. doi: 10.1007/s11096-020-01083-4. Epub 2020 Aug 28.

Improving adherence to oral anticancer therapy.

Nursing. 2013 Sep;43(9):31-6. doi: 10.1097/01.NURSE.0000432915.51753.0c.

Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.

J Oncol Pharm Pract. 2018 Jul;24(5):337-342. doi: 10.1177/1078155217703790. Epub 2017 Apr 7.

Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review.

Cancer Treat Rev. 2013 Oct;39(6):610-21. doi: 10.1016/j.ctrv.2012.12.014. Epub 2013 Feb 19.

Adherence to Oral Anticancer Therapeutics in the Gynecologic Oncology Population.

Obstet Gynecol. 2020 Dec;136(6):1145-1153. doi: 10.1097/AOG.0000000000004170.

Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.

Expert Opin Drug Saf. 2012 May;11 Suppl 1:S49-59. doi: 10.1517/14740338.2011.645803. Epub 2011 Dec 13.

What affects patient adherence to oral chemotherapy?

ONS Connect. 2012 Apr;27(4):24.

Adherence influencing factors in patients taking oral anticancer agents: a systematic review.

Cancer Epidemiol. 2014 Jun;38(3):214-26. doi: 10.1016/j.canep.2014.03.012. Epub 2014 Apr 24.

Adherence enhancing interventions for oral anticancer agents: a systematic review.

Cancer Treat Rev. 2014 Feb;40(1):102-8. doi: 10.1016/j.ctrv.2013.07.004. Epub 2013 Aug 1.

引用本文的文献

Tailoring oral targeted therapies dosage in lung cancer: A systematic review of pharmacokinetics studies on renal and hepatic impairment.

PLoS One. 2025 Jul 29;20(7):e0324056. doi: 10.1371/journal.pone.0324056. eCollection 2025.

Totality of the Evidence: Optimizing Dosage Selection Strategies in Oncology.

J Clin Oncol. 2025 Jul 24:JCO2500488. doi: 10.1200/JCO-25-00488.

"These Drugs Are Going to Save Our Lives" A Mixed Methods Study on the Role of Medication Perceptions in Adherence to Oral Anticancer Agents Among Patients With Gastrointestinal Tract Cancer.

Psychooncology. 2025 Jul;34(7):e70213. doi: 10.1002/pon.70213.

Managing adherence, exposure, and toxicity in oral anticancer therapies.

J Pharm Health Care Sci. 2025 Apr 7;11(1):28. doi: 10.1186/s40780-025-00437-2.

Cancer Treatment Disruption by Residence Region in the Aftermath of Hurricanes Irma and María in Puerto Rico.

Int J Environ Res Public Health. 2024 Oct 8;21(10):1334. doi: 10.3390/ijerph21101334.

Adherence, clinical benefits, and adverse effects of endocrine therapies among women with nonmetastatic breast cancer in developing countries: A systematic review and meta-analysis.

Cancer. 2025 Jan 1;131(1):e35550. doi: 10.1002/cncr.35550. Epub 2024 Sep 5.

Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study.

Cancers (Basel). 2024 Jun 11;16(12):2193. doi: 10.3390/cancers16122193.

Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial.

JCO Oncol Pract. 2024 Oct;20(10):1376-1383. doi: 10.1200/OP.24.00031. Epub 2024 Jun 25.

A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial.

PLoS One. 2024 Jun 7;19(6):e0304573. doi: 10.1371/journal.pone.0304573. eCollection 2024.

Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma.

PLoS One. 2023 Nov 16;18(11):e0294320. doi: 10.1371/journal.pone.0294320. eCollection 2023.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Call to Action for Improving Oral Anticancer Agent Adherence.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献